Dexamethasone attenuates the embryotoxic effect of endometriotic peritoneal fluid in a murine model

Journal of Assisted Reproduction and Genetics

Volumn 32, Issue 9, 2015, Pages 1317-1323

  Heitmann, Ryan J ^a   Tobler, Kyle J ^a   Gillette, Laurie ^a   Tercero, Juan ^a   Burney, Richard O ^a,b  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b Madigan Healthcare System   (United States)

Author keywords

Blastocyst; Dexamethasone; Embryo; Endometriosis; Infertility

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANTIINFLAMMATORY AGENT; CULTURE MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLASTOCYST; CONTROLLED STUDY; EMBRYO; EMBRYO CULTURE; EMBRYO DEVELOPMENT; EMBRYOTOXICITY; ENDOMETRIOSIS; FEMALE; MOUSE; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; ANIMAL; ASCITES FLUID; C57BL MOUSE; CASE CONTROL STUDY; COMPARATIVE STUDY; COMPLICATION; CULTURE MEDIUM; DRUG EFFECTS; HUMAN; INFERTILITY, FEMALE; MAMMALIAN EMBRYO; PATHOLOGY; PHARMACOLOGY; PHYSIOLOGY; PREGNANCY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASCITIC FLUID; CASE-CONTROL STUDIES; CULTURE MEDIA; DEXAMETHASONE; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY, FEMALE; MICE; MICE, INBRED C57BL; PREGNANCY;

EID: 84943355116     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-015-0516-0     Document Type: Article

References (42)

1. Eskenazi B, Warner ML. Epidemiology of endometriosis. Obstet Gynecol Clin N Am. 1997;24(2):235–58.
2. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril. 2002;77(6):1148–55.
3. Halis G, Arici A. Endometriosis and inflammation in infertility. Ann N Y Acad Sci. 2004;1034:300–15.
4. Ho HN, Wu MY, Chao KH, Chen CD, Chen SU, Chen HF, et al. Decrease in interferon gamma production and impairment of T-lymphocyte proliferation in peritoneal fluid of women with endometriosis. Am J Obstet Gynecol. 1996;175(5):1236–41.
5. Oral E, Olive DL, Arici A. The peritoneal environment in endometriosis. Hum Reprod Update. 1996;2(5):385–98.
6. Prough SG, Aksel S, Gilmore SM, Yeoman RR. Peritoneal fluid fractions from patients with endometriosis do not promote two-cell mouse embryo growth. Fertil Steril. 1990;54(5):927–30.
7. Morcos RN, Gibbons WE, Findley WE. Effect of peritoneal fluid on in vitro cleavage of 2-cell mouse embryos: possible role in infertility associated with endometriosis. Fertil Steril. 1985;44(5):678–83.
8. Wu MY, Chen SU, Chao KH, Chen CD, Yang YS, Ho HN. Mouse embryo toxicity of IL-6 in peritoneal fluids from women with or without endometriosis. Acta Obstet Gynecol Scand. 2001;80(1):7–11.
9. Gomez-Torres MJ, Acien P, Campos A, Velasco I. Embryotoxicity of peritoneal fluid in women with endometriosis. Its relation with cytokines and lymphocyte populations. Hum Reprod. 2002;17(3):777–81.
10. Esfandiari N, Falcone T, Goldberg JM, Agarwal A, Sharma RK. Effects of peritoneal fluid on preimplantation mouse embryo development and apoptosis in vitro. Reprod BioMed Online. 2005;11(5):615–9.
11. Noordin L, San GT, Singh HJ, Othman MS, Hafizah W. Pyruvate reduces in vitro the embryotoxic effect of peritoneal fluid from infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol. 2008;136(1):67–73.
12. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids–new mechanisms for old drugs. N Engl J Med. 2005;353(16):1711–23.
13. Eyster KM, Klinkova O, Kennedy V, Hansen KA. Whole genome deoxyribonucleic acid microarray analysis of gene expression in ectopic versus eutopic endometrium. Fertil Steril. 2007;88(6):1505–33.
14. Verhoog NJ, Du Toit A, Avenant C, Hapgood JP. Glucocorticoid-independent repression of tumor necrosis factor (TNF) alpha-stimulated interleukin (IL)-6 expression by the glucocorticoid receptor: a potential mechanism for protection against an excessive inflammatory response. J Biol Chem. 2011;286(22):19297–310.
15. Bider D, Amoday I, Tur-Kaspa I, Livshits A, Dor J. The addition of a glucocorticoid to the protocol of programmed oocyte retrieval for in-vitro fertilization–a randomized study. Hum Reprod. 1996;11(8):1606–8.
16. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997;67(5):817-21.
17. Fassbender A, Vodeolaskaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, et al. Biomarkers of endometriosis. Fertil Steril. 2013;99(4):1135–45.
18. Noyes R, Hertig A, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol. 1975;122:262–3.
19. Byers SL, Payson SJ, Taft RA. Performance of ten inbred mouse strains following assisted reproductive technologies (ARTs). Theriogenology. 2006;65(9):1716–26.
20. Nagy A, Gertsenstein M, Vintersten K, Behringer R. Manipulating the Mouse Embryo: a laboratory manual. New York: Cold Spring Harbor Laboratory Press; 2003.
21. Lane M, Gardner DK. Effect of incubation volume and embryo density on the development and viability of mouse embryos in vitro. Hum Reprod. 1992;7(4):558–62.
22. Lawitts JA, Biggers JD. Culture of preimplantation embryos. Methods Enzymol. 1993;225:153–64.
23. Navarro J, Garrido N, Remohi J, Pellicer A. How does endometriosis affect infertility? Obstet Gynecol Clin N Am. 2003;30(1):181–92.
24. Simon C, Gutierrez A, Vidal A, Santos MJ d l, Tarin JJ, Remohi J, et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod. 1994;9(4):725–9.
25. Ding GL, Chen XJ, Luo Q, Dong MY, Wang N, Huang HF. Attenuated oocyte fertilization and embryo development associated with altered growth factor/signal transduction induced by endometriotic peritoneal fluid. Fertil Steril. 2010;93(8):2538–44.
26. Mansour G, Abdelrazik H, Sharma RK, Radwan E, Falcone T, Agarwal A. L-carnitine supplementation reduces oocyte cytoskeleton damage and embryo apoptosis induced by incubation in peritoneal fluid from patients with endometriosis. Fertil Steril. 2009;91(5 Suppl):2079–86.
27. Hauzman EE, Garcia-Velasco JA, Pellicer A. Oocyte donation and endometriosis: what are the lessons? Semin Reprod Med. 2013;31(2):173–7.
28. Simon C, Gomez E, Mir A, Santos MJ D l, Pellicer A. Glucocorticoid treatment decreases sera embryotoxicity in endometriosis patients. Fertil Steril. 1992;58(2):284–9.
29. Bider D, Hourvitz A, Tur Kaspa I, Dirnfeld M, Dor J. Dexamethasone supplementation to gonadotropin stimulation for in vitro fertilization in polycystic ovarian disease. J Assist Reprod Genet. 1999;16(5):233–5.
30. Keay SD, Lenton EA, Cooke ID, Hull MG, Jenkins JM. Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme. Hum Reprod. 2001;16(9):1861–5.
31. Czock D, Keller F, Rasche FM, Haussler U. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44(1):61–98.
32. Lamiable D, Vistelle R, Sulmont V, Millart H, Caron J, Choisy H. Pharmacokinetics of dexamethasone administered orally in obese patients. Therapie. 1990;45(4):311–4.
33. Van Merris V, Van Wemmel K, Cortvrindt R. In vitro effects of dexamethasone on mouse ovarian function and pre-implantation embryo development. Reprod Toxicol. 2007;23(1):32–41.
34. Sasson R, Amsterdam A. Pleiotropic anti-apoptotic activity of glucocorticoids in ovarian follicular cells. Biochem Pharmacol. 2003;66(8):1393–401.
35. Kumar S, Allen DA, Kieswich JE, Patel NS, Harwood S, Mazzon E, et al. Dexamethasone ameliorates renal ischemia-reperfusion injury. J Am Soc Nephrol: JASN. 2009;20(11):2412–25.
36. Korgun ET, Dohr G, Desoye G, Demir R, Kayisli UA, Hahn T. Expression of insulin, insulin-like growth factor I and glucocorticoid receptor in rat uterus and embryo during decidualization, implantation and organogenesis. Reproduction (Cambridge, England). 2003;125(1):75–84.
37. Siemieniuch MJ, Majewska M, Takahashi M, Sakatani M, Lukasik K, Okuda K, et al. Are glucocorticoids auto- and/or paracrine factors in early bovine embryo development and implantation? Reprod Biol. 2010;10(3):249–56.
38. Pampfer S, Wuu YD, Vanderheyden I, De Hertogh R. Expression of tumor necrosis factor-alpha (TNF alpha) receptors and selective effect of TNF alpha on the inner cell mass in mouse blastocysts. Endocrinology. 1994;134(1):206–12.
39. Ben-Yair E, Less A, Lev S, Ben-Yehoshua L, Tartakovsky B. Tumour necrosis factor alpha binding to human and mouse trophoblast. Cytokine. 1997;9(11):830–6.
40. Kohchi C, Tanabe Y, Noguchi K, Mizuno D, Soma G. Induction of differentiation in embryonic stem cells by 26-kD membrane-bound tumor necrosis factor (TNF) and 17-kD free TNF. In vivo (Athens, Greece). 1996;10(1):19-27.
41. Wuu YD, Pampfer S, Vanderheyden I, Lee KH, De Hertogh R. Impact of tumor necrosis factor alpha on mouse embryonic stem cells. Biol Reprod. 1998;58(6):1416–24.
42. Pampfer S, Vanderheyden I, McCracken JE, Vesela J, De Hertogh R. Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro. Development (Cambridge, England). 1997;124(23):4827–36.